^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    PI16 overexpression

    i
    Other names: PI16 , Peptidase Inhibitor 16, Microseminoprotein, Beta-Binding Protein, Cysteine-Rich Secretory Protein 9, Protease Inhibitor 16, PSP94-Binding Protein, CRISP9, MSMBBP, CD364, PSPBP, CD364 Antigen, DJ90K10.5, MGC45378, CRISP-9
    Entrez ID:
    221476
    over2years
    Peptidase inhibitor (PI16) impairs bladder cancer metastasis by inhibiting NF-κB activation via disrupting multiple-site ubiquitination of NEMO. (PubMed, Cell Mol Biol Lett)
    These results indicate that PI16 functions as a tumour suppressor in BLCA by inhibiting tumour growth and metastasis. Additionally, PI16 may serve as a potential biomarker for metastatic BLCA.
    Journal
    |
    ANXA1 (Annexin A1) • PI16 (Peptidase Inhibitor 16)
    |
    PI16 overexpression